About
Technology
Issues
FAQ
Search
Profile
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Main Topics
Most Cited Articles
Scientometrics
Avg Impact Factor
★★
Articles
★★★
Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Schools
›
Division of Hematology/Oncology
›
top-articles
Division of Hematology/Oncology
280
(top 1%)
papers
11.2K
(top 1%)
citations
47
(top 1%)
h
-index
102
(top 1%)
g
-index
303
all documents
12.4K
doc citations
2.3K
citing journals
Top Articles
#
Title
Journal
Year
Citations
1
Myeloproliferative Neoplasia Remodels the Endosteal Bone Marrow Niche into a Self-Reinforcing Leukemic Niche
Cell Stem Cell
2013
532
2
Hematopoietic Stem Cell Quiescence Promotes Error-Prone DNA Repair and Mutagenesis
Cell Stem Cell
2010
521
3
Chronic interleukin-1 exposure drives haematopoietic stem cells towards precocious myeloid differentiation at the expense of self-renewal
Nature Cell Biology
2016
519
4
FOXO3A directs a protective autophagy program in haematopoietic stem cells
Nature
2013
518
5
Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC
Journal of Thoracic Oncology
2018
515
6
Functionally Distinct Subsets of Lineage-Biased Multipotent Progenitors Control Blood Production in Normal and Regenerative Conditions
Cell Stem Cell
2015
494
7
American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer
Blood Advances
2021
431
8
Rituximab therapy for CNS lymphomas: targeting the leptomeningeal compartment
Blood
2003
393
9
Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010
Blood
2005
390
10
Dual kinase-bromodomain inhibitors for rationally designed polypharmacology
Nature Chemical Biology
2014
296
11
Anti–Cytotoxic T-Lymphocyte Antigen-4 Antibody: The First in an Emerging Class of Immunomodulatory Antibodies for Cancer Treatment
Journal of Clinical Oncology
2008
294
12
DNA-Damage Response in Tissue-Specific and Cancer Stem Cells
Cell Stem Cell
2011
288
13
Efficacy and safety of pembrolizumab for the treatment of advanced biliary cancer: Results from the
KEYNOTE
‐158 and
KEYNOTE
‐028 studies
International Journal of Cancer
2020
288
14
Re-entry into quiescence protects hematopoietic stem cells from the killing effect of chronic exposure to type I interferons
Journal of Experimental Medicine
2014
246
15
13C-Pyruvate Imaging Reveals Alterations in Glycolysis that Precede c-Myc-Induced Tumor Formation and Regression
Cell Metabolism
2011
210
16
In situ vaccination against mycosis fungoides by intratumoral injection of a TLR9 agonist combined with radiation: a phase 1/2 study
Blood
2012
202
17
Circulating tumor DNA in neoadjuvant-treated breast cancer reflects response and survival
Annals of Oncology
2021
201
18
Cationic Liposomes Coated with Polyethylene Glycol As Carriers for Oligonucleotides
Journal of Biological Chemistry
1998
183
19
Pro-inflammatory cytokines: Emerging players regulating HSC function in normal and diseased hematopoiesis
Experimental Cell Research
2014
177
20
Lipid rafts and the local density of ErbB proteins influence the biological role of homo- and heteroassociations of ErbB2
Journal of Cell Science
2002
167
21
Immunotherapy in hepatocellular carcinoma: the complex interface between inflammation, fibrosis, and the immune response
2019
156
22
Myeloid progenitor cluster formation drives emergency and leukaemic myelopoiesis
Nature
2017
155
23
Novel Nanoliposomal CPT-11 Infused by Convection-Enhanced Delivery in Intracranial Tumors: Pharmacology and Efficacy
Cancer Research
2006
149
24
Potent efficacy of combined PI3K/mTOR and JAK or ABL inhibition in murine xenograft models of Ph-like acute lymphoblastic leukemia
Blood
2017
138
25
JunB Protects against Myeloid Malignancies by Limiting Hematopoietic Stem Cell Proliferation and Differentiation without Affecting Self-Renewal
Cancer Cell
2009
127
26
3D compressed sensing for highly accelerated hyperpolarized
13
C MRSI with in vivo applications to transgenic mouse models of cancer
Magnetic Resonance in Medicine
2010
126
27
Surviving change: the metabolic journey of hematopoietic stem cells
Trends in Cell Biology
2014
120
28
Impact of
68
Ga-PSMA-11 PET on Management in Patients with Biochemically Recurrent Prostate Cancer
Journal of Nuclear Medicine
2017
111
29
Phase 1 pharmacokinetic and drug‐interaction study of dasatinib in patients with advanced solid tumors
Cancer
2010
110
30
Activity of ponatinib against clinically-relevant AC220-resistant kinase domain mutants of FLT3-ITD
Blood
2013
110
31
The epidemiology of immune thrombocytopenic purpura
Current Opinion in Hematology
2007
106
32
A Phase II Study of Fixed-Dose Rate Gemcitabine Plus Low-Dose Cisplatin Followed by Consolidative Chemoradiation for Locally Advanced Pancreatic Cancer
International Journal of Radiation Oncology Biology Physics
2007
104
33
Immunochemotherapy with Intensive Consolidation for Primary CNS Lymphoma: A Pilot Study and Prognostic Assessment by Diffusion-Weighted MRI
Clinical Cancer Research
2012
104
34
Relationship between
MLH1
,
PMS2
,
MSH2
and
MSH6
gene‐specific alterations and tumor mutational burden in 1057 microsatellite instability‐high solid tumors
International Journal of Cancer
2020
102
35
Mechanisms controlling hematopoietic stem cell functions during normal hematopoiesis and hematological malignancies
Wiley Interdisciplinary Reviews: Systems Biology and Medicine
2011
96
36
NANETS/SNMMI Procedure Standard for Somatostatin Receptor–Based Peptide Receptor Radionuclide Therapy with
177
Lu-DOTATATE
Journal of Nuclear Medicine
2019
95
37
How to turn up the heat on the cold immune microenvironment of metastatic prostate cancer
Prostate Cancer and Prostatic Diseases
2021
93
38
Genomic Profiling of Isolated Circulating Tumor Cells from Metastatic Breast Cancer Patients
Cancer Research
2013
92
39
RADIA: RNA and DNA Integrated Analysis for Somatic Mutation Detection
PLoS ONE
2014
90
40
KTE-X19 anti-CD19 CAR T-cell therapy in adult relapsed/refractory acute lymphoblastic leukemia: ZUMA-3 phase 1 results
Blood
2021
90
41
Isolation and genomic analysis of circulating tumor cells from castration resistant metastatic prostate cancer
BMC Cancer
2012
85
42
Pooled analysis of AIDS malignancy consortium trials evaluating rituximab plus CHOP or infusional EPOCH chemotherapy in HIV‐associated non‐Hodgkin lymphoma
Cancer
2012
81
43
Assessment of the Efficacy of Therapies Following Venetoclax Discontinuation in CLL Reveals BTK Inhibition as an Effective Strategy
Clinical Cancer Research
2020
80
44
Cellular Mechanisms of Resistance to Anthracyclines and Taxanes in Cancer: Intrinsic and Acquired
Seminars in Oncology
2008
75
45
Self-monitoring and reminder text messages to increase physical activity in colorectal cancer survivors (Smart Pace): a pilot randomized controlled trial
BMC Cancer
2019
66
46
Detection of cerebrospinal fluid tumor cells and its clinical relevance in leptomeningeal metastasis of breast cancer
Breast Cancer Research and Treatment
2015
57
47
SARS-CoV-2 vaccination and ITP in patients with de novo or preexisting ITP
Blood
2022
55
48
Deep Sequencing Reveals Myeloma Cells in Peripheral Blood in Majority of Multiple Myeloma Patients
Clinical Lymphoma, Myeloma and Leukemia
2014
54
49
Genomic Sequencing: Assessing The Health Care System, Policy, And Big-Data Implications
Health Affairs
2014
53
50
Venetoclax induces deep hematologic remissions in t(11;14) relapsed/refractory AL amyloidosis
Blood Cancer Journal
2021
53
site/software ©
exaly
; All materials licenced under
CC by-SA
.